Loading...

Analysts Maintain €26 Target for Philogen as Buyback and Valuations Remain Stable

Published
20 Aug 25
Updated
05 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
16.0%
7D
-4.1%

Author's Valuation

€2610.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 05 Nov 25

PHIL: Share Buyback and Stable Metrics Expected to Sustain Fair Value

Narrative Update: Philogen Price Target Revision Analysts have maintained Philogen's fair value estimate at €26.00. Adjustments in future revenue growth and profit margin expectations are key supporting factors for this unchanged target.

Shared on 22 Oct 25

Analysts have maintained their price target for Philogen at €26.00 per share, citing stable expectations for key financial metrics and future performance. What's in the News Philogen completed the repurchase of 29,448 shares, representing 0.07% of total shares, for €0.66 million under the buyback program announced on May 12, 2025 (Key Developments).

Shared on 08 Oct 25

Fair value Decreased 7.14%

Analysts have lowered their price target for Philogen from $28.00 to $26.00. This decision is based on revisions in revenue growth projections and a significant reduction in estimated profit margins.